Send mail to Author

A head-to-head comparison of the efficacy and safety of ixekizumab and adalimumab in biological-naïve patients with active psoriatic arthritis: 24-week results of a randomised, open-label, blinded-assessor trial (Article)

Please indicate your contact information and select, which author you want to contact.



 
 ______     ______   __   __     ___      ______   _    _   
|      \\  /_   _//  \ \\/ //   / _ \\   /_____// | || | || 
|  --  //   -| ||-    \   //   | / \ ||  `____ `  | || | || 
|  --  \\   _| ||_    / . \\   | \_/ ||  /___//   | \\_/ || 
|______//  /_____//  /_//\_\\   \___//   `__ `     \____//  
`------`   `-----`   `-`  --`   `---`    /_//       `---`   
                                         `-`
 


Back to frontdoor view

OPUS4 Logo